These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28953788)

  • 1. Benzodiazepines in combination with antipsychotic drugs for schizophrenia: GABA-ergic targeted therapy.
    Włodarczyk A; Szarmach J; Cubała WJ; Wiglusz MS
    Psychiatr Danub; 2017 Sep; 29(Suppl 3):345-348. PubMed ID: 28953788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Benzodiazepines and schizophrenia, a review of the literature].
    Gaillard R; Ouanas A; Spadone C; Llorca PM; Lôo H; Baylé FJ
    Encephale; 2006; 32(6 Pt 1):1003-10. PubMed ID: 17372546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepines as adjunctive therapy in treatment refractory symptoms of schizophrenia.
    Szarmach J; Włodarczyk A; Cubała WJ; Wiglusz MS
    Psychiatr Danub; 2017 Sep; 29(Suppl 3):349-352. PubMed ID: 28953789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical review of GABA-ergic drugs in the treatment of schizophrenia.
    Wassef AA; Dott SG; Harris A; Brown A; O'Boyle M; Meyer WJ; Rose RM
    J Clin Psychopharmacol; 1999 Jun; 19(3):222-32. PubMed ID: 10350028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis.
    Gillies D; Beck A; McCloud A; Rathbone J; Gillies D
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003079. PubMed ID: 16235313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzodiazepines in schizophrenia.
    Stimmel GL
    Pharmacotherapy; 1996; 16(6 Pt 2):148S-151S; discussion 166S-168S. PubMed ID: 8947998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepines for schizophrenia.
    Volz A; Khorsand V; Gillies D; Leucht S
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006391. PubMed ID: 17253592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of polypharmacy on outcome in patients with schizophrenia in routine psychiatric treatment.
    Längle G; Steinert T; Weiser P; Schepp W; Jaeger S; Pfiffner C; Frasch K; Eschweiler GW; Messer T; Croissant D; Becker T; Kilian R
    Acta Psychiatr Scand; 2012 May; 125(5):372-81. PubMed ID: 22321029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between cortical inhibition, antipsychotic treatment, and the symptoms of schizophrenia.
    Liu SK; Fitzgerald PB; Daigle M; Chen R; Daskalakis ZJ
    Biol Psychiatry; 2009 Mar; 65(6):503-9. PubMed ID: 18950746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon.
    Guidotti A; Auta J; Davis JM; Dong E; Grayson DR; Veldic M; Zhang X; Costa E
    Psychopharmacology (Berl); 2005 Jul; 180(2):191-205. PubMed ID: 15864560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.
    Kapur S; Seeman P
    Am J Psychiatry; 2001 Mar; 158(3):360-9. PubMed ID: 11229973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of psychiatric medications in schizophrenia and other psychoses in a general population sample.
    Nykänen S; Puska V; Tolonen JP; Salo H; Isohanni M; Koponen H; Pirkola S; Penttilä M; Haapea M; Moilanen J; Miettunen J; Jääskeläinen E
    Psychiatry Res; 2016 Jan; 235():160-8. PubMed ID: 26652841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of GABA.
    Meldrum B
    Clin Neuropharmacol; 1982; 5(3):293-316. PubMed ID: 6214305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzodiazepines in schizophrenia: a need for reassessment.
    Nestoros JN
    Int Pharmacopsychiatry; 1980; 15(3):171-9. PubMed ID: 6113219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of psychosis: 30 years of progress.
    De Oliveira IR; Juruena MF
    J Clin Pharm Ther; 2006 Dec; 31(6):523-34. PubMed ID: 17176358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescribing Practice in Inpatients Versus Outpatients With Schizophrenia Initiating Treatment With Second-Generation Antipsychotics: A Naturalistic Follow-Up Study.
    Edlinger M; Rettenbacher MA; Kemmler G; Biedermann F; Widschwendter CG; Fleischhacker WW; Hofer A
    J Clin Psychopharmacol; 2016 Dec; 36(6):621-627. PubMed ID: 27662459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paroxysmal dystonia and psychotic exacerbations in chronic psychosis: Diagnostic dilemmas and preliminary treatment approaches.
    Mishra BR; Biswas T; Sreeraj VS; Nath S; Mohapatra D; Maiti R
    Br J Clin Pharmacol; 2023 Sep; 89(9):2926-2932. PubMed ID: 37160681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for psychotic symptoms concomitant with epilepsy.
    Farooq S; Sherin A
    Cochrane Database Syst Rev; 2008 Oct; (4):CD006118. PubMed ID: 18843704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.